Sprinklr Inc (CXM) concluded trading on Wednesday at a closing price of $9.06, with 4.58 million shares of worth about $41.47 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 9.95% during that period and on June 04, 2025 the price saw a gain of about 5.96%. Currently the company’s common shares owned by public are about 257.81M shares, out of which, 100.25M shares are available for trading.
Stock saw a price change of 7.60% in past 5 days and over the past one month there was a price change of 17.36%. Year-to-date (YTD), CXM shares are showing a performance of 7.22% which decreased to -19.18% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $6.75 but also hit the highest price of $11.01 during that period. The average intraday trading volume for Sprinklr Inc shares is 1.72 million. The stock is currently trading 8.84% above its 20-day simple moving average (SMA20), while that difference is up 13.89% for SMA50 and it goes to 10.16% higher than SMA200.
Sprinklr Inc (NYSE: CXM) currently have 257.81M outstanding shares and institutions hold larger chunk of about 39.77% of that.
The stock has a current market capitalization of $2.34B and its 3Y-monthly beta is at 0.81. PE ratio of stock for trailing 12 months is 22.08, while it has posted earnings per share of $0.41 in the same period. Its PEG reads 1.87 and has Quick Ratio of 1.57 while making debt-to-equity ratio of 0.08. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CXM, volatility over the week remained 3.98% while standing at 2.41% over the month.
Stock’s fiscal year EPS is expected to rise by 12.29% while it is estimated to increase by 10.99% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Cantor Fitzgerald on June 03, 2025 offering a Neutral rating for the stock and assigned a target price of $8 to it. On December 11, 2024, JP Morgan Downgrade their recommendations, while on November 19, 2024, Scotiabank Initiated their ratings for the stock with a price target of $7.70. Stock get an Underweight rating from Wells Fargo on November 12, 2024.
